Literature DB >> 7893842

Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.

F Lohr1, F Wenz, S Haas, M Flentje.   

Abstract

PC10 is a monoclonal antibody against proliferating cell nuclear antigen (PCNA). The staining pattern in immunochemistry depends on fixation and detergent extraction treatment. The aim of this study was to validate the flow cytometric PCNA assay against Bromodeoxyuridine-labelling index (BrdUrd-LI) under different proliferative conditions in vitro. Expression of PCNA in methanol fixed cells with, and without, prior detergent extraction with EDTA/Triton was compared to BrdUrd-labelling index in NIH-3T3 fibroblasts and human Caski tumour cells in exponential phase and under confluent conditions. Serum stimulation and serum starvation conditions were studied. The results for BrdUrd-LI and PCNA-index after extraction showed good correlation for 3T3 fibroblasts and for Caski cells, with some differences for serum withdrawn Caski cells. There was no correlation between the number of cells that were positive for PCNA without extraction and BrdUrd-LI. Spheroid cells with G1-DNA-content showed an almost synchronous recruitment and progression through the cell cycle after trypsination and replating. Tightly bound PCNA paralleled this synchronicity whereas total PCNA did not change significantly. The results demonstrate that immunochemical detection of non-extractable PCNA-index gives similar results as compared with BrdUrd-labelling index under different proliferative conditions in vitro for different monolayer cell lines, whereas without extraction PCNA does not correlate with BrdUrd-LI in these fast growing cell lines due to its long half-life. PCNA expression parallels the progression through the cell cycle in V79 spheroids, a primitive model of tumour growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7893842     DOI: 10.1111/j.1365-2184.1995.tb00058.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  8 in total

1.  NO66, a highly conserved dual location protein in the nucleolus and in a special type of synchronously replicating chromatin.

Authors:  Jens Eilbracht; Michaela Reichenzeller; Michaela Hergt; Martina Schnölzer; Hans Heid; Michael Stöhr; Werner W Franke; Marion S Schmidt-Zachmann
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

2.  Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature.

Authors:  J L Young; J N Benoit; D A Dean
Journal:  Gene Ther       Date:  2003-08       Impact factor: 5.250

3.  Chromatin-bound PCNA as S-phase marker in mononuclear blood cells of patients with acute lymphoblastic leukaemia or multiple myeloma.

Authors:  F Zölzer; O Basu; P U Devi; S P Mohanty; C Streffer
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

4.  Cytometry of chromatin bound Mcm6 and PCNA identifies two states in G1 that are separated functionally by the G1 restriction point.

Authors:  Phyllis S Frisa; James W Jacobberger
Journal:  BMC Cell Biol       Date:  2010-04-16       Impact factor: 4.241

5.  Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.

Authors:  Ying Xing; Yu Ning; Li-Qiang Ru; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

6.  X-ray induced changes in immunostaining of proliferating cell nuclear antigen (PCNA) in V79 hamster fibroblasts.

Authors:  F Lohr; H Hof; K J Weber; D Latz; F Wenz
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

7.  Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.

Authors:  M M Tinnemans; M H Lenders; G P ten Velde; S S Wagenaar; G H Blijham; F C Ramaekers; B Schutte
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Changes in the sensitivity of intratumor cells during fractionated tirapazamine administration.

Authors:  S Masunaga; K Ono; M Suzuki; Y Kinashi; M Takagaki; S Kasai; H Nagasawa; Y Uto; H Hori
Journal:  Jpn J Cancer Res       Date:  2000-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.